Affiliation:
1. Institute of Applied Biological Research of Guinea; Centre International de Recherche sur les Infections Tropicales en Guinée
2. St. Petersburg Pasteur Institute
3. Institute of Applied Biological Research of Guinea
Abstract
Rationale. Countries of Africa, especially countries in sub-Saharan Africa, represent a region characterized by high incidence of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Methods for detection of HBV and HCV in low and middle-income countries differ from those that are used in countries having access to high-cost technologies. The Republic of Guinea is a region with high prevalence of hepatotropic viruses, however, the information on HBV and HCV prevalence in the area is extremely limited, thus emphasizing the significance of this study.The purpose of the study is to evaluate the need for improving laboratory diagnostics of parenteral HBV and HCV infections in the Republic of Guinea.Materials and methods. A total of 2,616 samples of blood serum were tested, the samples were collected from apparently healthy residents of the Republic of Guinea during the routine medical checkup. The testing included qualitative detection of HBsAg, anti-HBs IgG, anti-HBcore IgG, anti-HCV IgG antibodies as well as HBV DNA and HCV RNA.Results. The detection frequency of serological markers of HBV and HCV infections was 80.77% and 18%, respectively. However, HBsAg was detected only in 16.01% of individuals. Tests for detection of HBV DNA were performed among seropositive patients and patients seronegative by other HBV markers, HBV DNA was detected in 22.36% of cases, including 6.07% of HBsAg-negative cases. HCV RNA was detected in 2.2% of cases. Both HCV RNA and HBV DNA were detected in 27 people, including 19 HBsAg-negative cases, thus accounting for 1.03% of the examined group.Conclusions. The markers that are currently used for laboratory detection of HBV and HCV in the Republic of Guinea are not efficient enough to diagnose reliably all cases. Undoubtedly, there is an urgent need to improve laboratory diagnostics for timely detection of parenteral viral hepatitis. Routine laboratory operations need assays for additional serological and molecular markers of HCV and HBV infections.
Publisher
Central Research Institute for Epidemiology
Reference28 articles.
1. WHO. Prevention and control of viral hepatitis infection: frame work for global action 2012. Geneva, 2012.
2. Mukomolov S.L., Levakova I.A. Epidemiological characteristics of chronic viral hepatitis in the Russian Federation in 1999– 2009. Infektsiya i immunitet. 2011, 1(3): 255–62. https://doi.org/10.15789/2220-7619-2011-3-255-262
3. Zabala V., Tong M., Yu R., Ramirez T., Yalcin E.B., Balbo S., et al. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease. Alcohol Alcohol. 2015, 50(2): 118–31. https://doi.org/10.1093/alcalc/agu083
4. Yim H.J., Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006, 43(2 Suppl. 1): S173–81. https://doi.org/10.1002/hep.20956
5. Yushchuk N.D., Klimova E.A., Znoyko O.O., Karetkina G.N., Maksimov S.L., Maev I.V. Viral hepatitis: clinic, diagnosis, treatment [Virusnye gepatity: klinika, diagnostika, lechenie]. Moscow: GEOTAR-Media, 2012. (in Russian)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献